Mandatory notification of trade
Gentian Diagnostics ASA (GENT) · publisert 12. februar 2026 kl. 16:09 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Njaal Kind | CFO | acquisition | 3 000 | 40 NOK | 12. februar 2026 | NO0010748866 | XOSL | llm |
Vedlegg
- 2026 02 12 Kind KRT-1500.pdf (tekst hentet ut)
Meldingstekst
Moss, 12 February 2026
Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction has been completed by a primary insider in Gentian:
Njaal Kind, Chief Financial Officer and primary insider in Gentian, has purchased 3,000 shares in Gentian at NOK 40.00 per share. Mr. Kind owns 29,128 shares and 140,670 options after this transaction.
PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is attached.
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article 19 and Euronext Oslo Rule Book II.
For further information, please contact: Njaal Kind, Group CFO, njaal.kind@gentian.no, +47 91 90 65 25